Clinical Trial Details

EORTC-62902

Back to Clinical Trials Database

PHASE II STUDY OF DAILY ORAL MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN ADVANCED SOFT TISSUE SARCOMAS OF THE ADULT.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 14-Jun-1990
Date Step1 close: 15-Mar-1991
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 25
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number